Odomzo Approved for Advanced Skin Cancer

The FDA has approved Odomzo (sonidegib) capsules for the treatment of adults with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.

Cancer Patients Need Fertility Preservation Awareness

Many young cancer patients have limited awareness about options to preserve their fertility.

ED Drugs and Melanoma Risk

Patients taking medications for erectile dysfunction (ED) may have an increased risk of melanoma but these drugs are not a cause of melanoma.

Chili Pepper Toxin, Gallbladder Cancer Risk

Gallbladder cancer seems to be associated with aflatoxin, according to a new study.

No Link Between PTSD, Cancer

While the potential relationship between stress and cancer has been a topic of discussion and research for over 70 years, no association between post-traumatic stress disorder (PTSD) and cancer was found in the largest study to date.

Cyramza Gains Colon Cancer Indication

The FDA has expanded the indication of Cyramza (ramucirumab; Eli Lilly) for use in combination with irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed on a first line bevacizumab-, oxaliplatin- and fluoropyrimidine-containing regimen.

Fish Oil May Hinder Chemotherapy Effectiveness

Fish oil supplements, and even certain fish, may hinder the effectiveness of chemotherapy.

Stroke Risk Up After Cancer Diagnosis

Cancer increases the risk of stroke independently of other stroke risk factors, such as hypertension and diabetes.

News

Daratumumab Monotherapy Promising for Multiple Myeloma

Daratumumab Monotherapy Promising for Multiple Myeloma

Daratumumab monotherapy has a favorable safety profile and encouraging efficacy in patients with heavily pretreated and refractory myeloma in a phase 1-2 trial.

Blood Test Promising in Detecting Cancer Relapse Early

Blood Test Promising in Detecting Cancer Relapse Early

An experimental blood test may one day detect the return of early-stage breast cancer months before it is revealed by computed tomography or magnetic resonance imaging.

ERCC1 SNP May Identify Good Prognosis in Nasopharyngeal CA

ERCC1 SNP May Identify Good Prognosis in Nasopharyngeal CA

Excision repair cross-complementing group 1 (ERCC1) genotype for the single nucleotide polymorphism (SNP) cytosine-to-thymine substitution at codon 118 (C118T) interacts with post-radiotherapy plasma Epstein-Barr virus (EBV) DNA (pEBV) to identify favorable prognosis for a subgroup of patients with nasopharyngeal carcinoma (NPC).

Report: Distress Common After False-Positive Mammogram

Report: Distress Common After False-Positive Mammogram

A majority of women who receive false positives on mammography experience distress and anxiety.

Genomic Approach Could Aid Risk Stratification in AML

Genomic Approach Could Aid Risk Stratification in AML

For adult patients with de novo acute myeloid leukemia (AML), persistent leukemia-associated mutations in ≥5% of bone marrow cells from remission samples is linked to increased risk of relapse and worse survival.

Charts

Make prescribing decisions with our comparative charts and treatment algorithms.

Patient Information Fact Sheets

Download or print easy-to-read disease leaflets for your patients.

Featured courses from myCME

Comprehensive Review of Radiation OncologyExternal web site

Radiation oncologists and residents will appreciate the experience of the renowned faculty of the Comprehensive ...

CME 24.00 Credits

Chronic Pain ManagementExternal web site

This activity is designed to change health provider attitudes on chronic pain and willingness to ...

CME|CE 2.00 Credits

Prostate Cancer: Optimism, Caution for Active SurveillanceExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters